Robert Fenton is the founder and CEO of Qualio , a cloud-based quality management system (eQMS) for life sciences teams. getty The start of a new year is often a time for reflection. However, looking forward is just as important—particularly in an industry as ever-changing as life science. As the effects of Covid-19 begin to loosen their grip, fresh headwinds should start to emerge. I see a year of both challenge and opportunity ahead as life science companies look to strike a delicate balance between innovation and speed on one hand and the realities of an economic downturn on the other. I see four key things happening in 2023. Those Who Collaborate Win In 2023 I previously wrote about how connectedness and interdependence would be the prevailing trend for successful life science companies in the 2020s. The shift in the economic environment since then with rising interest rates, runaway inflation and a steady teeter toward recession has only strengthened this impulse. New and emerging startups and scale-ups in 2023 simply won’t have the resources or capital to own the entire life cycles of their life-saving products. Outsourcing, collaboration and smart supplier onboarding (from clinical trials to raw materials) will […]
Four Predictions For A New Digital Life Science World In 2023
You may also like...
